MENU

KLRS Kalaris Therapeutics Inc Forecast, Technical & Fundamental Analysis

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases... Show more

KLRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
KLRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KLRS is expected to report earnings to rise 9.00% to -50 cents per share on August 19

Kalaris Therapeutics Inc KLRS Stock Earnings Reports
Q2'26
Est.
$-0.50
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.34
The last earnings report on May 12 showed earnings per share of -46 cents, beating the estimate of -56 cents. With 2.92K shares outstanding, the current market capitalization sits at 104.69M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMGRX73.88N/A
N/A
ClearBridge International Growth R
VMVFX17.01N/A
N/A
Vanguard Global Minimum Volatility Inv
ELMFX28.06N/A
N/A
Lord Abbett Emerging Markets Equity F
FEQDX15.83N/A
N/A
Fidelity Advisor Hedged Equity C
NEMCX26.41-0.25
-0.94%
Neuberger Emerg Mkts Eq C

KLRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with PTHS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-6.78%
PTHS - KLRS
43%
Loosely correlated
+0.97%
DARE - KLRS
24%
Poorly correlated
-5.53%
AEON - KLRS
23%
Poorly correlated
-1.32%
STTK - KLRS
23%
Poorly correlated
+5.86%
RIGL - KLRS
23%
Poorly correlated
+8.51%
More
Kalaris Therapeutics (KLRS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com